Healthcare provider profile · identity verified

Richard Cho, D.O.

Internal Medicine · YORKTOWN HEIGHTS, NY · NPI 1902867773

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	696	217
Atorvastatin Calcium	Atorvastatin Calcium	530	154
Olmesartan Medoxomil	Olmesartan Medoxomil	222	66
Amlodipine Besylate	Amlodipine Besylate	210	67
Levothyroxine Sodium	Levothyroxine Sodium	200	54
Escitalopram Oxalate	Escitalopram Oxalate	165	51
Sertraline Hcl	Sertraline Hcl	148	46
Losartan Potassium	Losartan Potassium	123	34
Pantoprazole Sodium	Pantoprazole Sodium	122	41
Ezetimibe	Ezetimibe	119	39
Felodipine Er	Felodipine	99	29
Metoprolol Succinate	Metoprolol Succinate	96	34
Trazodone Hcl	Trazodone Hcl	89	29
Metformin Hcl	Metformin Hcl	75	23
Metformin Hcl Er	Metformin Hcl	74	23
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	73	22
Simvastatin	Simvastatin	70	17
Omeprazole	Omeprazole	69	22
Valsartan	Valsartan	68	17
Tamsulosin Hcl	Tamsulosin Hcl	65	26
Labetalol Hcl	Labetalol Hcl	63	18
Hydrochlorothiazide	Hydrochlorothiazide	62	20
Duloxetine Hcl	Duloxetine Hcl	59	19
Irbesartan	Irbesartan	55	15
Pravastatin Sodium	Pravastatin Sodium	55	19
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	52	15
Famotidine	Famotidine	52	17
Alendronate Sodium	Alendronate Sodium	50	11
Synthroid	Levothyroxine Sodium	49	13
Eliquis	Apixaban	47	12
Venlafaxine Hcl Er	Venlafaxine Hcl	47	15
Carvedilol	Carvedilol	45	15
Jardiance	Empagliflozin	45	14
Lisinopril	Lisinopril	44	13
Telmisartan	Telmisartan	44	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	43	13
Bupropion Xl	Bupropion Hcl	40	14
Lovastatin	Lovastatin	40	11
Glimepiride	Glimepiride	39	12
Allopurinol	Allopurinol	35	12
Meloxicam	Meloxicam	35	14
Ramipril	Ramipril	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	11
Montelukast Sodium	Montelukast Sodium	31	suppressed
Nebivolol Hcl	Nebivolol Hcl	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	27	14
Fluticasone Propionate	Fluticasone Propionate	27	12
Methylprednisolone	Methylprednisolone	26	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Atenolol	Atenolol	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Vilazodone Hcl	Vilazodone Hcl	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Cefuroxime	Cefuroxime Axetil	21	21
Gabapentin	Gabapentin	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Furosemide	Furosemide	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Prednisone	Prednisone	18	17
Ozempic	Semaglutide	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	16	suppressed
Azithromycin	Azithromycin	16	15
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	13	suppressed
Twinrix	Hepatitis A And B Vaccine/Pf	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error